tiprankstipranks
Advertisement
Advertisement
TuHURA Biosciences initiated with a Buy at Rodman & Renshaw
PremiumThe FlyTuHURA Biosciences initiated with a Buy at Rodman & Renshaw
2M ago
TuHURA Biosciences Approves 2025 Executive Compensation Adjustments
Premium
Company Announcements
TuHURA Biosciences Approves 2025 Executive Compensation Adjustments
2M ago
TuHURA Biosciences files INDA for TBS-2025 in blood-related cancers
Premium
The Fly
TuHURA Biosciences files INDA for TBS-2025 in blood-related cancers
3M ago
TuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0
PremiumThe FlyTuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0
4M ago
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice
Premium
Company Announcements
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice
4M ago
TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright
Premium
The Fly
TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright
5M ago
TuHURA Biosciences presents research on potential role of DOR at ASH
PremiumThe FlyTuHURA Biosciences presents research on potential role of DOR at ASH
6M ago
TuHURA Biosciences Amends Loan Agreement, Secures Full $3M
Premium
Company Announcements
TuHURA Biosciences Amends Loan Agreement, Secures Full $3M
6M ago
TuHURA Biosciences’ Shelf Registration Statement Effective
Premium
Company Announcements
TuHURA Biosciences’ Shelf Registration Statement Effective
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100